Pathology and Lab Medicine

220

LikeLikedUnlike

Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
GI Insights
Developments in Colorectal Cancer Screening: Cell-Free DNA Blood Testing
- Peter Buch, MD, FACG, AGAF, FACP
  Peer
- William Grady, MD
  Peer
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
On the Frontlines of IgA Nephropathy
Diagnosing IgA Nephropathy: The Role of Immunofluorescence and Immunohistochemistry
- Gates B. Colbert, MD
  Peer
- Agnes B. Fogo, MD
  Peer
What to Know About the No Surprises Act
Perspectives with the AMA
What to Know About the No Surprises Act
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Emily Carroll, JD, MSW
  Peer
Advocacy Efforts During the COVID-19 Pandemic
Perspectives with the AMA
Advocacy Efforts During the COVID-19 Pandemic
- Jennifer Caudle, DO
  Peer
- Todd Askew
  Peer
Lyme: The First Epidemic of Climate Change
Book Club
Lyme: The First Epidemic of Climate Change
- Mary Beth Pfeiffer
  Peer
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
Book Club
The Vaccine Race: Science, Politics, & the Human Costs of Defeating Disease
- John Russell, MD
  Peer
- Meredith Wadman, BM, BCh, M.S.
  Peer

Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
CME/CE Broadcast Replay
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
- John H. Stone, MD, MPH
  Peer
- Yoh Zen, MD, PhD, FRCPath
  Peer
- Avinash Kambadakone-Ramesh, MD, DNB, FRCR
  Peer
- J. Matthias Löhr, MD
  Peer
1.00 credits
The Evolving Role of MET TKIs in NSCLC
CME/CE
The Evolving Role of MET TKIs in NSCLC
- Gilberto de Lima Lopes, Jr, MD, MBA, FASCO
  Peer
- Jyoti Patel, MD
  Peer
0.75 credits
MinuteCE®
Precision Timing: Unveiling the Impact of CDK4/6 Inhibition in Early HR+/HER2- Breast Cancer
- Hope S. Rugo, MD, FASCO
  Peer
- Nadia Harbeck, MD, PhD
  Peer
1.25 credits 10 episodes
Treatment Intensification in HR+/HER2- EBC: Who and When?
MinuteCE®
Treatment Intensification in HR+/HER2- EBC: Who and When?
- Hope S. Rugo, MD, FASCO
  Peer
- Nadia Harbeck, MD, PhD
  Peer
1.25 program credits
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
MinuteCE®
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
- Hope S. Rugo, MD, FASCO
  Peer
- Nadia Harbeck, MD, PhD
  Peer
1.25 program credits
Recent updates from adjuvant trials in HR+/HER2- EBC
MinuteCE®
Recent updates from adjuvant trials in HR+/HER2- EBC
- Nadia Harbeck, MD, PhD
  Peer
1.25 program credits

Helping Ensure Adequate Tissue Sampling Within the MDT
Medical Industry Feature
Helping Ensure Adequate Tissue Sampling Within the MDT
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Pre-Testing: Working Together Toward Testing
Medical Industry Feature
Pre-Testing: Working Together Toward Testing
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Interpreting Test Results and Making the Treatment Decision Within the MDT
Medical Industry Feature
Interpreting Test Results and Making the Treatment Decision Within the MDT
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer
Advocate for the Pathologist Within the MDT
Medical Industry Feature
Advocate for the Pathologist Within the MDT
- Michael Overman, MD
  Peer
- Anil Parwani, MD, PhD
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended